A new trading day began on Monday, with Morphosys AG ADR (NASDAQ: MOR) stock price down -3.77% from the previous day of trading, before settling in for the closing price of $18.04. MOR’s price has ranged from $4.18 to $18.31 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 67.37% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 24.77%. With a float of $150.21 million, this company’s outstanding shares have now reached $150.41 million.
In an organization with 564 employees, it is important to assess its efficiency.
Morphosys AG ADR (MOR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Morphosys AG ADR is 0.30%, while institutional ownership is 15.79%.
Morphosys AG ADR (MOR) Latest Financial update
In its latest quarterly report, released on 12/31/2023, the company reported earnings of -0.36 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.77% per share during the next fiscal year.
Morphosys AG ADR (NASDAQ: MOR) Trading Performance Indicators
Here are Morphosys AG ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.56 in the next quarter and is forecasted to reach -0.87 in one year’s time.
Technical Analysis of Morphosys AG ADR (MOR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.07 million. That was inferior than the volume of 1.72 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 59.99%. Additionally, its Average True Range was 0.21.
During the past 100 days, Morphosys AG ADR’s (MOR) raw stochastic average was set at 92.01%, which indicates a significant increase from 28.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.42% in the past 14 days, which was lower than the 99.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.93, while its 200-day Moving Average is $10.84. However, in the short run, Morphosys AG ADR’s stock first resistance to watch stands at $17.63. Second resistance stands at $17.91. The third major resistance level sits at $18.20. If the price goes on to break the first support level at $17.06, it is likely to go to the next support level at $16.77. The third support level lies at $16.49 if the price breaches the second support level.
Morphosys AG ADR (NASDAQ: MOR) Key Stats
With a market capitalization of 2.62 billion, the company has a total of 150,621K Shares Outstanding. Currently, annual sales are 257,890 K while annual income is -205,350 K. The company’s previous quarter sales were 63,610 K while its latest quarter income was 53,170 K.
